BioLargo Inc (OTCQB:BLGO), an innovator of sustainable science and technology and full-service environmental engineering company announced that its Canadian subsidiary has received a commitment of $235,000 for a pre-commercial pilot project for its Advanced Oxidation System (AOS). As quoted in the press release: The funding will be provided by the National Research Council of Canada … Continued
BioLargo Inc (OTCQB:BLGO), an innovator of sustainable science and technology and full-service environmental engineering company announced that its Canadian subsidiary has received a commitment of $235,000 for a pre-commercial pilot project for its Advanced Oxidation System (AOS).
As quoted in the press release:
The funding will be provided by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), Canada’s premier industrial innovation assistance program for small and medium-sized enterprises (SMEs). With this support, BioLargo’s AOS has received approximately CA$500,000 in total contributions to date from the NRC IRAP. The pilot will demonstrate the AOS’ ability to disinfect and decontaminate water at high flow-rates, allowing for recycling, reuse, and/or safe water discharge. Moreover, continuous treatment and recycling of the processed water in this pilot project will allow for a comprehensive assessment of the long term economic advantage (both operating and capital costs) and conservation benefits of the AOS for both energy and water, in comparison with conventional wastewater treatment technologies. Ultimately, the company expects the results of this pilot will lay an important foundation for the technical and business case that convinces future customers to purchase the AOS.
This pilot project and the NRC IRAP funding that supports it represents an important milestone in the company’s efforts to develop and commercialize the AOS, its patented and innovative water treatment platform technology. The AOS is, in essence, the result of a marriage between advances in iodine electrochemistry and materials engineering of carbon compounds, and data suggest it could lead to substantial economic and water savings in multiple industries. A pilot project for the AOS, as with any technology, is crucial to prove its reliability to industry stakeholders as well the capital cost and operating costs of our technology at-scale. These data will be critical to pave the way for future market adoption.
“This contribution will allow BioLargo Water to move forward with a long-term pilot in wastewater treatment to validate its ability to meet reuse standards,” said Richard Smith, BioLargo Water’s president. “The continued support from NRC IRAP indicates the potential of our technology and demonstrates the need for our AOS on the global market. We thank the Government of Canada and NRC IRAP for their support.”
BioLargo, Inc.’s President and CEO Dennis Calvert said, “This pre-commercial pilot is an important step toward commercial production of our flagship AOS product. Our engineering team is working with our Canadian researchers and industrial stakeholders to push this product toward client installations and sales. We are working with a facility that processes six to eight thousand chickens per week, and we believe this project will directly lead to significant water and money savings for this client, as well as help prove up our value proposition in real-world conditions. We expect to operate our AOS on-site for an extended period of time under real life operating conditions.”
As is true with all novel technologies, field testing is critical to evaluate and refine the data in support of durability, capital cost, operating cost, and extended performance metrics.
“We believe our AOS technology can help the food processing industry improve its water overall self-sufficiency, reduce wastewater disposal costs and improve its continued march to improve its commitment to sustainability,” Calvert said. “We also believe the deployment of the AOS will save this industry money and water, both long term and short term, and the data we will develop in this commercial pilot will help us validate those claims.”